Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Exchange Rate Effect (2023 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Exchange Rate Effect for 3 consecutive years, with $84000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect rose 300.0% to $84000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$46000.0, a 224.32% decrease, with the full-year FY2024 number at -$149000.0, down 720.83% from a year prior.
  • Exchange Rate Effect was $84000.0 for Q3 2025 at Xtant Medical Holdings, up from -$19000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $84000.0 in Q3 2025 to a low of -$109000.0 in Q4 2024.
  • A 3-year average of -$1125.0 and a median of -$7000.0 in 2024 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: tumbled 241.56% in 2024, then soared 300.0% in 2025.
  • Xtant Medical Holdings' Exchange Rate Effect stood at $77000.0 in 2023, then crashed by 241.56% to -$109000.0 in 2024, then soared by 177.06% to $84000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Exchange Rate Effect are $84000.0 (Q3 2025), -$19000.0 (Q2 2025), and -$2000.0 (Q1 2025).